Your SlideShare is downloading. ×
0
New & Emerging Drugs
At the Coal Face: The Victorian
Experience
Dr Keri Alexander
Addiction Medicine Specialist
Turning Po...
The Big Unknown
•
•
•
•

Patients aren’t screened
Patients / carers aren’t divulging
No monitoring from the hospitals
Anec...
What about monitoring from DACAS?
• Inherently biased/ opportunistic calls
• Ad hoc reporting
• Nil strategic research dat...
How to treat

???
Case of SW
•
•
•
•

22yr old man
6 year history of cannabis use
First two years were marijuana
Past 4 years were synthetic...
Case SW cont
• Reported escalating tolerance to each brand/
product over time, relieved by switching
brands

• History of ...
From the coal face: the Victorian experience - Dr Keri Alexander - DrugInfo   seminar - New and emerging drugs
Upcoming SlideShare
Loading in...5
×

From the coal face: the Victorian experience - Dr Keri Alexander - DrugInfo seminar - New and emerging drugs

643

Published on

Patients presenting with complications from new and emerging drugs are appearing in the hospital system. Currently, there is little known about how best to treat them. Presentations include requests for detoxification, as well as crisis, e.g. acute psychiatric complications. No practical screening system is in place, so this is an example of how we have to adapt to the circumstances. Dr Alexander presents a case study.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
643
On Slideshare
0
From Embeds
0
Number of Embeds
5
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "From the coal face: the Victorian experience - Dr Keri Alexander - DrugInfo seminar - New and emerging drugs"

  1. 1. New & Emerging Drugs At the Coal Face: The Victorian Experience Dr Keri Alexander Addiction Medicine Specialist Turning Point Eastern Health YSAS
  2. 2. The Big Unknown • • • • Patients aren’t screened Patients / carers aren’t divulging No monitoring from the hospitals Anecdotal from professional networks eg VAILA (hospital D&A nurses and specialists) • Unknown drug content
  3. 3. What about monitoring from DACAS? • Inherently biased/ opportunistic calls • Ad hoc reporting • Nil strategic research data collection and analysis
  4. 4. How to treat ???
  5. 5. Case of SW • • • • 22yr old man 6 year history of cannabis use First two years were marijuana Past 4 years were synthetic cannabis
  6. 6. Case SW cont • Reported escalating tolerance to each brand/ product over time, relieved by switching brands • History of withdrawal symptoms, which varied between brands (possibly co-incidental) • Costs $400 per week ie $20,000 per year
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×